TLR9 Adjuvants Enhance Immunogenicity and Protective Efficacy of the SE36/AHG Malaria Vaccine in Nonhuman Primate Models

Human Vaccines and Immunotherapeutics - United States
doi 10.4161/hv.22950
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Multi-Subunit BCG Booster Vaccine GamTBvac: Assessment of Immunogenicity and Protective Efficacy in Murine and Guinea Pig TB Models

PLoS ONE
Multidisciplinary
2017English

Nonhuman Primate Models in Translational Regenerative Medicine

Stem Cells and Development
Developmental BiologyHematologyCell Biology
2014English

Immunogenicity of a Vaccine Formulated With the Chlamydia Trachomatis Serovar F, Native Major Outer Membrane Protein in a Nonhuman Primate Model

Vaccine
Molecular MedicinePublic HealthVeterinaryMicrobiology EnvironmentalImmunologyInfectious DiseasesOccupational Health
2011English

Preclinical Studies on a New Vaccine Formulation of BK-SE36, a Malaria Vaccine Candidate

Juntendo Medical Journal
2015English

A Combined Analysis of Immunogenicity, Antibody Kinetics and Vaccine Efficacy From Phase 2 Trials of the RTS,S Malaria Vaccine

BMC Medicine
Medicine
2014English

Immunogenicity and Protective Efficacy of Seasonal Human Live Attenuated Cold-Adapted Influenza Virus Vaccine in Pigs

Frontiers in Immunology
AllergyImmunology
2019English

Nonhuman Primate Models of Social Behavior and Cocaine Abuse

Psychopharmacology
Pharmacology
2012English

Safety and Immunogenicity of RTS,S/AS02D Malaria Vaccine in Infants

New England Journal of Medicine
Medicine
2008English

Enhancement of the Immunogenicity and Protective Efficacy of a Mucosal Influenza Subunit Vaccine by the Saponin Adjuvant GPI-0100

PLoS ONE
Multidisciplinary
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy